FF:11366-117I7: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity=C | |sample_ethnicity=C | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;9.94055380698969e-234!GO:0005737;cytoplasm;1.87484691841574e-194!GO:0044444;cytoplasmic part;2.16784664219283e-146!GO:0043226;organelle;1.32368051495339e-133!GO:0043229;intracellular organelle;2.20056898521944e-133!GO:0043231;intracellular membrane-bound organelle;1.43774810442479e-130!GO:0043227;membrane-bound organelle;1.88632588662697e-130!GO:0044422;organelle part;3.90216259757832e-117!GO:0044446;intracellular organelle part;1.45364819833957e-115!GO:0032991;macromolecular complex;8.80516571468078e-82!GO:0005515;protein binding;1.25936260581034e-76!GO:0030529;ribonucleoprotein complex;4.31986454221775e-74!GO:0005739;mitochondrion;8.60227947319776e-65!GO:0044237;cellular metabolic process;5.10938778041777e-57!GO:0044238;primary metabolic process;1.34855211303592e-56!GO:0043233;organelle lumen;4.15016409829203e-56!GO:0031974;membrane-enclosed lumen;4.15016409829203e-56!GO:0031090;organelle membrane;1.72662289316467e-55!GO:0003723;RNA binding;4.68745487183543e-52!GO:0019538;protein metabolic process;5.41053629579272e-51!GO:0005840;ribosome;3.86914932818141e-50!GO:0043170;macromolecule metabolic process;3.29411934402963e-49!GO:0006412;translation;5.0818380001746e-48!GO:0044260;cellular macromolecule metabolic process;5.40880563688835e-46!GO:0044428;nuclear part;1.17918839464757e-45!GO:0003735;structural constituent of ribosome;2.63282550317347e-45!GO:0044267;cellular protein metabolic process;3.33650791001019e-45!GO:0044429;mitochondrial part;8.68411269266757e-44!GO:0009058;biosynthetic process;1.45909597522259e-43!GO:0043234;protein complex;9.03440177988071e-41!GO:0009059;macromolecule biosynthetic process;9.15388436773676e-41!GO:0015031;protein transport;3.88981106424599e-40!GO:0005829;cytosol;3.99711825908457e-40!GO:0016043;cellular component organization and biogenesis;1.15637728349476e-39!GO:0033036;macromolecule localization;3.21995204652602e-39!GO:0044249;cellular biosynthetic process;3.21995204652602e-39!GO:0033279;ribosomal subunit;7.98377817207905e-39!GO:0045184;establishment of protein localization;1.46441905825832e-37!GO:0008104;protein localization;9.726616176853e-37!GO:0031967;organelle envelope;2.21823455890282e-35!GO:0031975;envelope;4.92611986666802e-35!GO:0006396;RNA processing;5.21919270274833e-34!GO:0046907;intracellular transport;5.39247643968949e-31!GO:0005740;mitochondrial envelope;9.83311905605694e-30!GO:0005830;cytosolic ribosome (sensu Eukaryota);4.67493759805849e-29!GO:0031981;nuclear lumen;5.57909066948237e-29!GO:0005634;nucleus;1.14482277357389e-28!GO:0031966;mitochondrial membrane;7.94348549167359e-28!GO:0005783;endoplasmic reticulum;1.13574807572633e-27!GO:0016071;mRNA metabolic process;1.15460781098739e-26!GO:0006886;intracellular protein transport;4.36515306074526e-26!GO:0019866;organelle inner membrane;9.00675432261875e-26!GO:0005743;mitochondrial inner membrane;6.86711854386168e-25!GO:0008380;RNA splicing;7.52762689737568e-25!GO:0065003;macromolecular complex assembly;3.23987732813148e-24!GO:0044445;cytosolic part;3.55390225075553e-24!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.05421097292732e-23!GO:0012505;endomembrane system;2.10448974817563e-23!GO:0006119;oxidative phosphorylation;5.40690720056089e-23!GO:0006397;mRNA processing;1.21288725746162e-22!GO:0006996;organelle organization and biogenesis;3.06026224427792e-22!GO:0043228;non-membrane-bound organelle;7.14112712083049e-22!GO:0043232;intracellular non-membrane-bound organelle;7.14112712083049e-22!GO:0022607;cellular component assembly;3.03181684263439e-21!GO:0044432;endoplasmic reticulum part;3.81622275365781e-21!GO:0044455;mitochondrial membrane part;1.2779320766934e-20!GO:0006457;protein folding;1.46535944999727e-20!GO:0005794;Golgi apparatus;1.60307338058516e-20!GO:0015934;large ribosomal subunit;3.91235355605326e-20!GO:0015935;small ribosomal subunit;1.18336699508659e-19!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;1.24467003565621e-19!GO:0016462;pyrophosphatase activity;1.30711475822478e-19!GO:0051641;cellular localization;1.30711475822478e-19!GO:0051649;establishment of cellular localization;1.5412103918117e-19!GO:0016817;hydrolase activity, acting on acid anhydrides;1.78070760502202e-19!GO:0017111;nucleoside-triphosphatase activity;4.02178079510155e-19!GO:0043283;biopolymer metabolic process;7.21749113475733e-18!GO:0005746;mitochondrial respiratory chain;1.1034577529972e-17!GO:0005681;spliceosome;1.51645020166458e-17!GO:0031980;mitochondrial lumen;3.42658571313346e-17!GO:0005759;mitochondrial matrix;3.42658571313346e-17!GO:0048770;pigment granule;3.8571634997402e-17!GO:0042470;melanosome;3.8571634997402e-17!GO:0005654;nucleoplasm;2.64205103467741e-16!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;4.40145953524328e-16!GO:0000166;nucleotide binding;8.78022362118789e-16!GO:0000502;proteasome complex (sensu Eukaryota);1.64137757592051e-15!GO:0050136;NADH dehydrogenase (quinone) activity;1.94899674840963e-15!GO:0003954;NADH dehydrogenase activity;1.94899674840963e-15!GO:0008137;NADH dehydrogenase (ubiquinone) activity;1.94899674840963e-15!GO:0042175;nuclear envelope-endoplasmic reticulum network;2.52196884175452e-15!GO:0010467;gene expression;2.68399526581223e-15!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);8.0892710468679e-15!GO:0005789;endoplasmic reticulum membrane;1.04944420647188e-14!GO:0051186;cofactor metabolic process;1.05685342727296e-14!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);1.16708116085118e-14!GO:0044265;cellular macromolecule catabolic process;1.40220575136658e-14!GO:0043285;biopolymer catabolic process;2.19867268139181e-14!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;2.96772234419323e-14!GO:0016192;vesicle-mediated transport;3.39658758693571e-14!GO:0016874;ligase activity;3.41912659051453e-14!GO:0048193;Golgi vesicle transport;4.69218029127572e-14!GO:0006605;protein targeting;4.86222369145158e-14!GO:0005730;nucleolus;5.54370618119309e-14!GO:0008134;transcription factor binding;5.80491524234035e-14!GO:0009057;macromolecule catabolic process;6.15587996534314e-14!GO:0051082;unfolded protein binding;6.69378179841012e-14!GO:0006512;ubiquitin cycle;1.06854998411014e-13!GO:0044451;nucleoplasm part;1.26168056585414e-13!GO:0030964;NADH dehydrogenase complex (quinone);1.26168056585414e-13!GO:0045271;respiratory chain complex I;1.26168056585414e-13!GO:0005747;mitochondrial respiratory chain complex I;1.26168056585414e-13!GO:0022618;protein-RNA complex assembly;1.33464036440224e-13!GO:0044248;cellular catabolic process;1.43980024989489e-13!GO:0005761;mitochondrial ribosome;1.89252741326154e-13!GO:0000313;organellar ribosome;1.89252741326154e-13!GO:0042775;organelle ATP synthesis coupled electron transport;1.97831688338175e-13!GO:0042773;ATP synthesis coupled electron transport;1.97831688338175e-13!GO:0051603;proteolysis involved in cellular protein catabolic process;3.7931113680353e-13!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;4.02068718246022e-13!GO:0019941;modification-dependent protein catabolic process;6.63201859737044e-13!GO:0043632;modification-dependent macromolecule catabolic process;6.63201859737044e-13!GO:0044257;cellular protein catabolic process;8.54390469380581e-13!GO:0006511;ubiquitin-dependent protein catabolic process;1.36658411069808e-12!GO:0008135;translation factor activity, nucleic acid binding;1.39401530522826e-12!GO:0005793;ER-Golgi intermediate compartment;1.46896875826573e-12!GO:0030163;protein catabolic process;1.47544918324725e-12!GO:0006259;DNA metabolic process;1.93125458539358e-12!GO:0009055;electron carrier activity;2.23333113960175e-12!GO:0012501;programmed cell death;7.97048359209411e-12!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;9.10992213330346e-12!GO:0006915;apoptosis;1.50192141330225e-11!GO:0016491;oxidoreductase activity;1.71598257481411e-11!GO:0032553;ribonucleotide binding;1.71598257481411e-11!GO:0032555;purine ribonucleotide binding;1.71598257481411e-11!GO:0017076;purine nucleotide binding;1.79562864063045e-11!GO:0006732;coenzyme metabolic process;2.54334911873051e-11!GO:0043412;biopolymer modification;2.63923456037774e-11!GO:0009259;ribonucleotide metabolic process;4.48986617731718e-11!GO:0042254;ribosome biogenesis and assembly;8.33694553214128e-11!GO:0006464;protein modification process;1.48753426641966e-10!GO:0048523;negative regulation of cellular process;1.80510044251525e-10!GO:0009150;purine ribonucleotide metabolic process;1.80510044251525e-10!GO:0006163;purine nucleotide metabolic process;1.90360909509059e-10!GO:0008219;cell death;2.0767075845627e-10!GO:0016265;death;2.0767075845627e-10!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;2.95680883113318e-10!GO:0007049;cell cycle;3.99946821313568e-10!GO:0009260;ribonucleotide biosynthetic process;5.2978616276297e-10!GO:0009152;purine ribonucleotide biosynthetic process;5.99520300101055e-10!GO:0006164;purine nucleotide biosynthetic process;6.8177039199658e-10!GO:0003743;translation initiation factor activity;8.70665371427098e-10!GO:0000398;nuclear mRNA splicing, via spliceosome;1.65665873275273e-09!GO:0000375;RNA splicing, via transesterification reactions;1.65665873275273e-09!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.65665873275273e-09!GO:0008639;small protein conjugating enzyme activity;1.83796210164479e-09!GO:0009199;ribonucleoside triphosphate metabolic process;1.86089924547743e-09!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;2.70363931434359e-09!GO:0003924;GTPase activity;2.90003550896694e-09!GO:0044431;Golgi apparatus part;2.99454742250082e-09!GO:0004842;ubiquitin-protein ligase activity;3.61746176534255e-09!GO:0009205;purine ribonucleoside triphosphate metabolic process;3.71071305132179e-09!GO:0009144;purine nucleoside triphosphate metabolic process;3.71071305132179e-09!GO:0048519;negative regulation of biological process;4.06520524890055e-09!GO:0003712;transcription cofactor activity;4.07418277727622e-09!GO:0009141;nucleoside triphosphate metabolic process;4.23355951717756e-09!GO:0009142;nucleoside triphosphate biosynthetic process;4.91613414973676e-09!GO:0009201;ribonucleoside triphosphate biosynthetic process;4.91613414973676e-09!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;7.38370850053427e-09!GO:0030120;vesicle coat;7.38370850053427e-09!GO:0030662;coated vesicle membrane;7.38370850053427e-09!GO:0016887;ATPase activity;7.38370850053427e-09!GO:0015986;ATP synthesis coupled proton transport;7.38370850053427e-09!GO:0015985;energy coupled proton transport, down electrochemical gradient;7.38370850053427e-09!GO:0005788;endoplasmic reticulum lumen;7.59095845343027e-09!GO:0006413;translational initiation;7.63805498258852e-09!GO:0006913;nucleocytoplasmic transport;9.41656580849793e-09!GO:0006888;ER to Golgi vesicle-mediated transport;9.63505158959379e-09!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;9.63505158959379e-09!GO:0009145;purine nucleoside triphosphate biosynthetic process;9.63505158959379e-09!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;1.00326206306809e-08!GO:0019787;small conjugating protein ligase activity;1.04280411444056e-08!GO:0009056;catabolic process;1.65215049300495e-08!GO:0005524;ATP binding;1.75676203730723e-08!GO:0051169;nuclear transport;1.81392259794182e-08!GO:0032559;adenyl ribonucleotide binding;2.3863864285172e-08!GO:0042623;ATPase activity, coupled;3.04854413923962e-08!GO:0030554;adenyl nucleotide binding;3.17717157587345e-08!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;3.33074467905005e-08!GO:0043069;negative regulation of programmed cell death;3.45747610323056e-08!GO:0005773;vacuole;3.55631977771808e-08!GO:0019829;cation-transporting ATPase activity;3.81174989257915e-08!GO:0006446;regulation of translational initiation;3.81174989257915e-08!GO:0006916;anti-apoptosis;4.53445803398525e-08!GO:0022402;cell cycle process;4.55382971296128e-08!GO:0043067;regulation of programmed cell death;4.67914254228124e-08!GO:0005768;endosome;5.16103686825109e-08!GO:0046034;ATP metabolic process;5.36975608806206e-08!GO:0016879;ligase activity, forming carbon-nitrogen bonds;5.38127422540315e-08!GO:0043687;post-translational protein modification;5.46989728710666e-08!GO:0048475;coated membrane;5.67441094759457e-08!GO:0030117;membrane coat;5.67441094759457e-08!GO:0009060;aerobic respiration;5.90194469179784e-08!GO:0042981;regulation of apoptosis;5.98121139036401e-08!GO:0007249;I-kappaB kinase/NF-kappaB cascade;6.4266269739116e-08!GO:0043066;negative regulation of apoptosis;7.52973541272202e-08!GO:0016881;acid-amino acid ligase activity;7.98625019137727e-08!GO:0008565;protein transporter activity;8.02261973249041e-08!GO:0006754;ATP biosynthetic process;1.2360079529338e-07!GO:0006753;nucleoside phosphate metabolic process;1.2360079529338e-07!GO:0017038;protein import;1.26993900305221e-07!GO:0051188;cofactor biosynthetic process;1.54567535693011e-07!GO:0006461;protein complex assembly;1.60577190826538e-07!GO:0051246;regulation of protein metabolic process;1.62565474141373e-07!GO:0015078;hydrogen ion transmembrane transporter activity;1.80774061030672e-07!GO:0006091;generation of precursor metabolites and energy;2.54378672878967e-07!GO:0005635;nuclear envelope;2.56121316819601e-07!GO:0016604;nuclear body;3.30882789229623e-07!GO:0045333;cellular respiration;3.58446744488382e-07!GO:0044453;nuclear membrane part;3.87939291712602e-07!GO:0000278;mitotic cell cycle;3.93696544944956e-07!GO:0009117;nucleotide metabolic process;3.96260800927007e-07!GO:0000323;lytic vacuole;4.2413152783201e-07!GO:0005764;lysosome;4.2413152783201e-07!GO:0006399;tRNA metabolic process;5.00416338853838e-07!GO:0006364;rRNA processing;5.16918576511461e-07!GO:0016072;rRNA metabolic process;5.3152580013173e-07!GO:0031988;membrane-bound vesicle;5.38437089543956e-07!GO:0016023;cytoplasmic membrane-bound vesicle;5.7241669703072e-07!GO:0031965;nuclear membrane;6.02805213425858e-07!GO:0000139;Golgi membrane;6.07927184624839e-07!GO:0016787;hydrolase activity;6.7958608811485e-07!GO:0005839;proteasome core complex (sensu Eukaryota);7.30389163903547e-07!GO:0030532;small nuclear ribonucleoprotein complex;1.01378404395741e-06!GO:0016469;proton-transporting two-sector ATPase complex;1.14183747018877e-06!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;1.55830228519752e-06!GO:0004812;aminoacyl-tRNA ligase activity;1.55830228519752e-06!GO:0016875;ligase activity, forming carbon-oxygen bonds;1.55830228519752e-06!GO:0005798;Golgi-associated vesicle;2.026554841302e-06!GO:0051187;cofactor catabolic process;2.04052890825478e-06!GO:0006099;tricarboxylic acid cycle;2.08845615961368e-06!GO:0046356;acetyl-CoA catabolic process;2.08845615961368e-06!GO:0048522;positive regulation of cellular process;2.53158687112967e-06!GO:0051726;regulation of cell cycle;2.61293828243495e-06!GO:0051789;response to protein stimulus;2.64235824643194e-06!GO:0006986;response to unfolded protein;2.64235824643194e-06!GO:0043038;amino acid activation;2.96012064157701e-06!GO:0006418;tRNA aminoacylation for protein translation;2.96012064157701e-06!GO:0043039;tRNA aminoacylation;2.96012064157701e-06!GO:0006974;response to DNA damage stimulus;3.14058946567697e-06!GO:0000074;regulation of progression through cell cycle;3.39498089541469e-06!GO:0045259;proton-transporting ATP synthase complex;3.91338116659004e-06!GO:0005770;late endosome;4.11908915013129e-06!GO:0007005;mitochondrion organization and biogenesis;4.46743817936665e-06!GO:0065002;intracellular protein transport across a membrane;5.21020559946828e-06!GO:0044440;endosomal part;5.2932790025549e-06!GO:0010008;endosome membrane;5.2932790025549e-06!GO:0009109;coenzyme catabolic process;5.59857412792367e-06!GO:0006752;group transfer coenzyme metabolic process;5.92581326436393e-06!GO:0031982;vesicle;6.20498462514171e-06!GO:0008361;regulation of cell size;6.78006977200527e-06!GO:0006325;establishment and/or maintenance of chromatin architecture;7.61693316631076e-06!GO:0016049;cell growth;7.74132244152807e-06!GO:0031410;cytoplasmic vesicle;7.91925116455345e-06!GO:0001558;regulation of cell growth;7.92856387991034e-06!GO:0006084;acetyl-CoA metabolic process;8.01985901150279e-06!GO:0004298;threonine endopeptidase activity;8.06647645331575e-06!GO:0008654;phospholipid biosynthetic process;8.91168919139427e-06!GO:0009108;coenzyme biosynthetic process;9.33060306535117e-06!GO:0031968;organelle outer membrane;9.9313642765269e-06!GO:0005525;GTP binding;1.01199190087081e-05!GO:0045454;cell redox homeostasis;1.08621343203143e-05!GO:0019867;outer membrane;1.13218643436149e-05!GO:0065004;protein-DNA complex assembly;1.20631184587221e-05!GO:0030036;actin cytoskeleton organization and biogenesis;1.22166457828956e-05!GO:0016853;isomerase activity;1.2298187965755e-05!GO:0016567;protein ubiquitination;1.23219618372638e-05!GO:0015077;monovalent inorganic cation transmembrane transporter activity;1.29836101339899e-05!GO:0032446;protein modification by small protein conjugation;1.32145147843585e-05!GO:0016607;nuclear speck;1.3415318356704e-05!GO:0005643;nuclear pore;1.72912060383532e-05!GO:0031252;leading edge;1.82338363769098e-05!GO:0008026;ATP-dependent helicase activity;1.84566829955661e-05!GO:0006323;DNA packaging;1.90356436783115e-05!GO:0003714;transcription corepressor activity;2.06506631473819e-05!GO:0004386;helicase activity;2.15273066390203e-05!GO:0006366;transcription from RNA polymerase II promoter;2.51397847445133e-05!GO:0005762;mitochondrial large ribosomal subunit;2.84299478197795e-05!GO:0000315;organellar large ribosomal subunit;2.84299478197795e-05!GO:0016740;transferase activity;3.83577338937344e-05!GO:0006281;DNA repair;4.35313116856542e-05!GO:0006613;cotranslational protein targeting to membrane;4.4788891993064e-05!GO:0030867;rough endoplasmic reticulum membrane;4.77853425039204e-05!GO:0005905;coated pit;4.8445248409643e-05!GO:0005741;mitochondrial outer membrane;5.33047537820909e-05!GO:0051170;nuclear import;5.33763419681429e-05!GO:0000151;ubiquitin ligase complex;5.39109894377331e-05!GO:0032561;guanyl ribonucleotide binding;6.08387332310396e-05!GO:0019001;guanyl nucleotide binding;6.08387332310396e-05!GO:0044262;cellular carbohydrate metabolic process;6.24925135528187e-05!GO:0006793;phosphorus metabolic process;6.37527080983412e-05!GO:0006796;phosphate metabolic process;6.37527080983412e-05!GO:0046930;pore complex;6.40984005602608e-05!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;6.44245768571857e-05!GO:0015399;primary active transmembrane transporter activity;6.44245768571857e-05!GO:0006606;protein import into nucleus;6.83436979059765e-05!GO:0019843;rRNA binding;7.23858502171457e-05!GO:0009719;response to endogenous stimulus;7.7687998664176e-05!GO:0016310;phosphorylation;7.7687998664176e-05!GO:0033116;ER-Golgi intermediate compartment membrane;7.8318041505088e-05!GO:0051276;chromosome organization and biogenesis;8.01831149172378e-05!GO:0006334;nucleosome assembly;8.5009048011314e-05!GO:0016859;cis-trans isomerase activity;8.5009048011314e-05!GO:0030133;transport vesicle;9.33001421199406e-05!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.000105084083590719!GO:0016564;transcription repressor activity;0.000107107956196631!GO:0016779;nucleotidyltransferase activity;0.000109743493691546!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.000110639521841089!GO:0006333;chromatin assembly or disassembly;0.00012547200151118!GO:0043623;cellular protein complex assembly;0.000127793944666594!GO:0007243;protein kinase cascade;0.000128358528849903!GO:0005667;transcription factor complex;0.000136733708026186!GO:0046474;glycerophospholipid biosynthetic process;0.000141756630087106!GO:0030029;actin filament-based process;0.000142959652584171!GO:0003697;single-stranded DNA binding;0.000154469033070424!GO:0005048;signal sequence binding;0.000159564459692486!GO:0000245;spliceosome assembly;0.00018298588499966!GO:0015980;energy derivation by oxidation of organic compounds;0.000219321749025432!GO:0048518;positive regulation of biological process;0.000219636205401452!GO:0045786;negative regulation of progression through cell cycle;0.000253712876445177!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.000258938826367351!GO:0006403;RNA localization;0.000266990103446514!GO:0003713;transcription coactivator activity;0.00026728354925862!GO:0050657;nucleic acid transport;0.000274658156402946!GO:0051236;establishment of RNA localization;0.000274658156402946!GO:0050658;RNA transport;0.000274658156402946!GO:0000087;M phase of mitotic cell cycle;0.000290830350243088!GO:0031324;negative regulation of cellular metabolic process;0.000293411996410147!GO:0007067;mitosis;0.000306622569123349!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;0.000320321600658768!GO:0030663;COPI coated vesicle membrane;0.000343069916825131!GO:0030126;COPI vesicle coat;0.000343069916825131!GO:0030176;integral to endoplasmic reticulum membrane;0.000352496832896737!GO:0000314;organellar small ribosomal subunit;0.000364850305626418!GO:0005763;mitochondrial small ribosomal subunit;0.000364850305626418!GO:0009165;nucleotide biosynthetic process;0.000401215842975711!GO:0030659;cytoplasmic vesicle membrane;0.000414851406543704!GO:0003724;RNA helicase activity;0.000415823939709515!GO:0005769;early endosome;0.000416429410971324!GO:0006612;protein targeting to membrane;0.000422062685615373!GO:0031497;chromatin assembly;0.000423688040988344!GO:0005885;Arp2/3 protein complex;0.000424283953502855!GO:0040008;regulation of growth;0.000471184135224927!GO:0022403;cell cycle phase;0.000471900505948923!GO:0016044;membrane organization and biogenesis;0.000476611662792967!GO:0006950;response to stress;0.000500210709819271!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.000507867645019073!GO:0065009;regulation of a molecular function;0.000512626191491341!GO:0009967;positive regulation of signal transduction;0.00051891385419642!GO:0043492;ATPase activity, coupled to movement of substances;0.000521776987299594!GO:0043021;ribonucleoprotein binding;0.000525526496892925!GO:0006260;DNA replication;0.000526568689816426!GO:0006118;electron transport;0.000566475467176752!GO:0030658;transport vesicle membrane;0.000600291057370174!GO:0006414;translational elongation;0.000606954459232302!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.000607419744673858!GO:0046489;phosphoinositide biosynthetic process;0.000628687785623078!GO:0043566;structure-specific DNA binding;0.000680129405349679!GO:0005694;chromosome;0.000703717396581165!GO:0016563;transcription activator activity;0.000753996745509894!GO:0000785;chromatin;0.000777507473331957!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.0007899929784859!GO:0030137;COPI-coated vesicle;0.000794669145078806!GO:0043284;biopolymer biosynthetic process;0.00082674037843708!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.000864818087121471!GO:0044433;cytoplasmic vesicle part;0.000955764209575771!GO:0016772;transferase activity, transferring phosphorus-containing groups;0.000975435903086818!GO:0051427;hormone receptor binding;0.00100656719900272!GO:0051920;peroxiredoxin activity;0.00104740870703056!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00115568278112358!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00118786068112924!GO:0009892;negative regulation of metabolic process;0.0011914328393395!GO:0043681;protein import into mitochondrion;0.00119219043191116!GO:0008632;apoptotic program;0.00124366880977239!GO:0016627;oxidoreductase activity, acting on the CH-CH group of donors;0.00136015780275115!GO:0006891;intra-Golgi vesicle-mediated transport;0.00142263942042069!GO:0003676;nucleic acid binding;0.00145275025001429!GO:0042802;identical protein binding;0.00149174393833512!GO:0007010;cytoskeleton organization and biogenesis;0.00149174393833512!GO:0008250;oligosaccharyl transferase complex;0.00151084956023965!GO:0004576;oligosaccharyl transferase activity;0.00151084956023965!GO:0044427;chromosomal part;0.00156380478584411!GO:0022890;inorganic cation transmembrane transporter activity;0.00157369504167679!GO:0031072;heat shock protein binding;0.0015987119901876!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00166727892786077!GO:0006626;protein targeting to mitochondrion;0.00173993946605949!GO:0015630;microtubule cytoskeleton;0.00177206232062571!GO:0046467;membrane lipid biosynthetic process;0.00179518369895175!GO:0030660;Golgi-associated vesicle membrane;0.00189382795575148!GO:0035257;nuclear hormone receptor binding;0.00189579147513989!GO:0012506;vesicle membrane;0.00190565467082437!GO:0008047;enzyme activator activity;0.00194587000300051!GO:0045792;negative regulation of cell size;0.00197241398316069!GO:0030308;negative regulation of cell growth;0.00197241398316069!GO:0003899;DNA-directed RNA polymerase activity;0.0020984821421165!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.0020984821421165!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.0020984821421165!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.0020984821421165!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.00215329145290968!GO:0005791;rough endoplasmic reticulum;0.00226621518086791!GO:0008610;lipid biosynthetic process;0.00229159371152115!GO:0030118;clathrin coat;0.00265666110601109!GO:0005774;vacuolar membrane;0.00280219822476857!GO:0016568;chromatin modification;0.00286177080165715!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00286233531789515!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.00293582994636363!GO:0007264;small GTPase mediated signal transduction;0.00293582994636363!GO:0018196;peptidyl-asparagine modification;0.00293582994636363!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.00293582994636363!GO:0007006;mitochondrial membrane organization and biogenesis;0.00302176120591221!GO:0019899;enzyme binding;0.00304267006851764!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00304598010488306!GO:0048468;cell development;0.00310715614057813!GO:0051028;mRNA transport;0.00311452304208426!GO:0051301;cell division;0.0032080070340054!GO:0030132;clathrin coat of coated pit;0.00324066442416933!GO:0048487;beta-tubulin binding;0.0034917933963938!GO:0048471;perinuclear region of cytoplasm;0.0035003068740022!GO:0006497;protein amino acid lipidation;0.00366211673871514!GO:0008092;cytoskeletal protein binding;0.00368491534008338!GO:0001666;response to hypoxia;0.00408063665963803!GO:0030134;ER to Golgi transport vesicle;0.00413921728194407!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.00414453316899634!GO:0008243;plasminogen activator activity;0.00428846900696168!GO:0006595;polyamine metabolic process;0.00437027329647816!GO:0016197;endosome transport;0.00447231662247698!GO:0008186;RNA-dependent ATPase activity;0.00473042479154541!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.00478878117128971!GO:0015002;heme-copper terminal oxidase activity;0.00478878117128971!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.00478878117128971!GO:0004129;cytochrome-c oxidase activity;0.00478878117128971!GO:0006509;membrane protein ectodomain proteolysis;0.00487692955936263!GO:0033619;membrane protein proteolysis;0.00487692955936263!GO:0006650;glycerophospholipid metabolic process;0.0049059546583971!GO:0048500;signal recognition particle;0.00491180830041918!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.00491180830041918!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.00491180830041918!GO:0051168;nuclear export;0.00501145910556691!GO:0043433;negative regulation of transcription factor activity;0.00501381657409206!GO:0030127;COPII vesicle coat;0.00518215999194326!GO:0012507;ER to Golgi transport vesicle membrane;0.00518215999194326!GO:0030041;actin filament polymerization;0.00527416601818418!GO:0017166;vinculin binding;0.00528643630727412!GO:0045045;secretory pathway;0.00528643630727412!GO:0051329;interphase of mitotic cell cycle;0.00544013072845199!GO:0030027;lamellipodium;0.00556871737023274!GO:0007033;vacuole organization and biogenesis;0.00567733787512453!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.00567733787512453!GO:0046519;sphingoid metabolic process;0.00616011105590507!GO:0007040;lysosome organization and biogenesis;0.00625454708683029!GO:0016706;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;0.0064955924966786!GO:0006082;organic acid metabolic process;0.00653742636389645!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.00661710285667598!GO:0044437;vacuolar part;0.00676327694583266!GO:0008139;nuclear localization sequence binding;0.00683697923257214!GO:0006506;GPI anchor biosynthetic process;0.00695574967166747!GO:0015992;proton transport;0.00723850366640502!GO:0019752;carboxylic acid metabolic process;0.00730344086331495!GO:0030125;clathrin vesicle coat;0.00731093336732438!GO:0030665;clathrin coated vesicle membrane;0.00731093336732438!GO:0006818;hydrogen transport;0.00779801739373145!GO:0016281;eukaryotic translation initiation factor 4F complex;0.00802912772099182!GO:0006839;mitochondrial transport;0.008782795270448!GO:0051540;metal cluster binding;0.00886779830837416!GO:0051536;iron-sulfur cluster binding;0.00886779830837416!GO:0042158;lipoprotein biosynthetic process;0.00920242656344357!GO:0030880;RNA polymerase complex;0.00924152574373284!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00924152574373284!GO:0003746;translation elongation factor activity;0.00952662800792358!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.00965825004380481!GO:0031902;late endosome membrane;0.00978999040262326!GO:0005765;lysosomal membrane;0.00981514273844375!GO:0003729;mRNA binding;0.00985512559431952!GO:0008154;actin polymerization and/or depolymerization;0.0103223329745522!GO:0004004;ATP-dependent RNA helicase activity;0.0103311369624578!GO:0051325;interphase;0.0104903792638345!GO:0005813;centrosome;0.0104903792638345!GO:0043161;proteasomal ubiquitin-dependent protein catabolic process;0.010531462980151!GO:0051087;chaperone binding;0.0105340656216736!GO:0004177;aminopeptidase activity;0.0106703011488116!GO:0045926;negative regulation of growth;0.0106703011488116!GO:0006778;porphyrin metabolic process;0.0106740747846606!GO:0033013;tetrapyrrole metabolic process;0.0106740747846606!GO:0046483;heterocycle metabolic process;0.0106740747846606!GO:0045941;positive regulation of transcription;0.0107861870033314!GO:0008180;signalosome;0.0108312088247545!GO:0003756;protein disulfide isomerase activity;0.0108312088247545!GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;0.0108312088247545!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.0109292697799772!GO:0030119;AP-type membrane coat adaptor complex;0.0109901574370455!GO:0051252;regulation of RNA metabolic process;0.0110218172973933!GO:0005869;dynactin complex;0.0110764625042458!GO:0006505;GPI anchor metabolic process;0.0111574291169821!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.0114596978778937!GO:0045047;protein targeting to ER;0.0114596978778937!GO:0006401;RNA catabolic process;0.011980076883576!GO:0016070;RNA metabolic process;0.0120503194435809!GO:0001726;ruffle;0.0120547558246352!GO:0005862;muscle thin filament tropomyosin;0.0127323544820349!GO:0045893;positive regulation of transcription, DNA-dependent;0.0129346918449622!GO:0050811;GABA receptor binding;0.0133371695614121!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0141890391910105!GO:0008312;7S RNA binding;0.0142606911073065!GO:0005815;microtubule organizing center;0.014445824781383!GO:0006402;mRNA catabolic process;0.0145985421134264!GO:0005684;U2-dependent spliceosome;0.0152670538182821!GO:0000059;protein import into nucleus, docking;0.0152967970798443!GO:0016126;sterol biosynthetic process;0.015337371664854!GO:0006672;ceramide metabolic process;0.015337371664854!GO:0006383;transcription from RNA polymerase III promoter;0.0153458263123017!GO:0022408;negative regulation of cell-cell adhesion;0.0153458263123017!GO:0000786;nucleosome;0.0154082840324973!GO:0000030;mannosyltransferase activity;0.0154082840324973!GO:0006979;response to oxidative stress;0.0155261278946309!GO:0031301;integral to organelle membrane;0.0157472479671024!GO:0008283;cell proliferation;0.0158273472471664!GO:0006354;RNA elongation;0.0158273472471664!GO:0050790;regulation of catalytic activity;0.0158947641959237!GO:0044452;nucleolar part;0.0161346243850323!GO:0006007;glucose catabolic process;0.0164615167778785!GO:0016272;prefoldin complex;0.016517298032597!GO:0015631;tubulin binding;0.0167142181340247!GO:0000279;M phase;0.016724352928806!GO:0007034;vacuolar transport;0.0167880971710901!GO:0031543;peptidyl-proline dioxygenase activity;0.0170699655933119!GO:0030145;manganese ion binding;0.0171141636300935!GO:0031418;L-ascorbic acid binding;0.0173046720664725!GO:0006693;prostaglandin metabolic process;0.0173046720664725!GO:0006692;prostanoid metabolic process;0.0173046720664725!GO:0030384;phosphoinositide metabolic process;0.0173759255578092!GO:0030131;clathrin adaptor complex;0.0182375721047987!GO:0055029;nuclear DNA-directed RNA polymerase complex;0.0182924909708536!GO:0000428;DNA-directed RNA polymerase complex;0.0182924909708536!GO:0042168;heme metabolic process;0.0183455017885627!GO:0006740;NADPH regeneration;0.0187081647075695!GO:0006098;pentose-phosphate shunt;0.0187081647075695!GO:0007050;cell cycle arrest;0.0189975064934307!GO:0033673;negative regulation of kinase activity;0.0189975064934307!GO:0006469;negative regulation of protein kinase activity;0.0189975064934307!GO:0006897;endocytosis;0.020023952741978!GO:0010324;membrane invagination;0.020023952741978!GO:0032940;secretion by cell;0.0204676818192023!GO:0030521;androgen receptor signaling pathway;0.0206975034092022!GO:0016481;negative regulation of transcription;0.020739665120254!GO:0051045;negative regulation of membrane protein ectodomain proteolysis;0.0208556472982439!GO:0051043;regulation of membrane protein ectodomain proteolysis;0.0208556472982439!GO:0035258;steroid hormone receptor binding;0.0210189638112981!GO:0043022;ribosome binding;0.0212926863401603!GO:0019205;nucleobase, nucleoside, nucleotide kinase activity;0.0213444434829228!GO:0006417;regulation of translation;0.0214094543228706!GO:0005096;GTPase activator activity;0.0214094543228706!GO:0043488;regulation of mRNA stability;0.021896772564828!GO:0043487;regulation of RNA stability;0.021896772564828!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.0219675425975681!GO:0000082;G1/S transition of mitotic cell cycle;0.022284438140673!GO:0016860;intramolecular oxidoreductase activity;0.022284438140673!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0226140100639195!GO:0001953;negative regulation of cell-matrix adhesion;0.0231754138381836!GO:0007162;negative regulation of cell adhesion;0.0232852105516605!GO:0051098;regulation of binding;0.0235064582958195!GO:0051348;negative regulation of transferase activity;0.0237660715377196!GO:0031227;intrinsic to endoplasmic reticulum membrane;0.0241055034918591!GO:0006458;'de novo' protein folding;0.0243881442399508!GO:0051084;'de novo' posttranslational protein folding;0.0243881442399508!GO:0006984;ER-nuclear signaling pathway;0.0246407471605246!GO:0016628;oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor;0.0247468898298485!GO:0051235;maintenance of localization;0.0248157826216565!GO:0030433;ER-associated protein catabolic process;0.0252324388349936!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0252324388349936!GO:0003711;transcription elongation regulator activity;0.0252917905306467!GO:0031529;ruffle organization and biogenesis;0.0257052869273474!GO:0035035;histone acetyltransferase binding;0.0257137292925992!GO:0005100;Rho GTPase activator activity;0.0260558957010082!GO:0019798;procollagen-proline dioxygenase activity;0.0260731009091719!GO:0005975;carbohydrate metabolic process;0.0266723321763935!GO:0008637;apoptotic mitochondrial changes;0.026725448284287!GO:0046870;cadmium ion binding;0.0268016778943287!GO:0005832;chaperonin-containing T-complex;0.0271947039269291!GO:0032507;maintenance of cellular protein localization;0.0272430440531358!GO:0000049;tRNA binding;0.0272975923643444!GO:0007030;Golgi organization and biogenesis;0.0280124134852294!GO:0050662;coenzyme binding;0.0280124134852294!GO:0007178;transmembrane receptor protein serine/threonine kinase signaling pathway;0.0283878035407959!GO:0051059;NF-kappaB binding;0.0285737749814853!GO:0046426;negative regulation of JAK-STAT cascade;0.0286593651739611!GO:0007041;lysosomal transport;0.028867899251604!GO:0031625;ubiquitin protein ligase binding;0.0290989396919675!GO:0051287;NAD binding;0.0297357339078428!GO:0050794;regulation of cellular process;0.0298536642870771!GO:0030833;regulation of actin filament polymerization;0.0298536642870771!GO:0006779;porphyrin biosynthetic process;0.0299540667846702!GO:0033014;tetrapyrrole biosynthetic process;0.0299540667846702!GO:0051101;regulation of DNA binding;0.0302233965212647!GO:0006289;nucleotide-excision repair;0.0307030114751056!GO:0031272;regulation of pseudopodium formation;0.0307179349224892!GO:0031269;pseudopodium formation;0.0307179349224892!GO:0031344;regulation of cell projection organization and biogenesis;0.0307179349224892!GO:0031268;pseudopodium organization and biogenesis;0.0307179349224892!GO:0031346;positive regulation of cell projection organization and biogenesis;0.0307179349224892!GO:0031274;positive regulation of pseudopodium formation;0.0307179349224892!GO:0006368;RNA elongation from RNA polymerase II promoter;0.0309218940012825!GO:0022415;viral reproductive process;0.0316794111961008!GO:0008538;proteasome activator activity;0.0320175791387391!GO:0016363;nuclear matrix;0.0320612791922339!GO:0008033;tRNA processing;0.0320931907224872!GO:0045936;negative regulation of phosphate metabolic process;0.0328659789393112!GO:0031901;early endosome membrane;0.0328659789393112!GO:0005819;spindle;0.0330939795580916!GO:0051128;regulation of cellular component organization and biogenesis;0.0332654285611033!GO:0009112;nucleobase metabolic process;0.034104203860782!GO:0022407;regulation of cell-cell adhesion;0.034961548990404!GO:0051539;4 iron, 4 sulfur cluster binding;0.0355213432800094!GO:0000209;protein polyubiquitination;0.0357757566840927!GO:0048144;fibroblast proliferation;0.0360715632988325!GO:0048145;regulation of fibroblast proliferation;0.0360715632988325!GO:0009889;regulation of biosynthetic process;0.0362584703671294!GO:0005801;cis-Golgi network;0.0368483313469575!GO:0045185;maintenance of protein localization;0.0375743498342418!GO:0005092;GDP-dissociation inhibitor activity;0.0382367054286142!GO:0043065;positive regulation of apoptosis;0.0382367054286142!GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;0.0382367054286142!GO:0031326;regulation of cellular biosynthetic process;0.0393176163822364!GO:0008484;sulfuric ester hydrolase activity;0.0395183857595592!GO:0050178;phenylpyruvate tautomerase activity;0.0395374140192169!GO:0008475;procollagen-lysine 5-dioxygenase activity;0.0395374140192169!GO:0051272;positive regulation of cell motility;0.0395374140192169!GO:0040017;positive regulation of locomotion;0.0395374140192169!GO:0032981;mitochondrial respiratory chain complex I assembly;0.039652248305252!GO:0010257;NADH dehydrogenase complex assembly;0.039652248305252!GO:0033108;mitochondrial respiratory chain complex assembly;0.039652248305252!GO:0019318;hexose metabolic process;0.039775389331321!GO:0006643;membrane lipid metabolic process;0.0400943967119451!GO:0006892;post-Golgi vesicle-mediated transport;0.0407622437607331!GO:0008147;structural constituent of bone;0.0410798512591806!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0416566724470653!GO:0006807;nitrogen compound metabolic process;0.0420295743582477!GO:0005996;monosaccharide metabolic process;0.0420401798735205!GO:0043068;positive regulation of programmed cell death;0.0424473285791512!GO:0031589;cell-substrate adhesion;0.0425672443352175!GO:0001516;prostaglandin biosynthetic process;0.0425672443352175!GO:0046457;prostanoid biosynthetic process;0.0425672443352175!GO:0000339;RNA cap binding;0.0425672443352175!GO:0007160;cell-matrix adhesion;0.0432675706282432!GO:0030911;TPR domain binding;0.0435933462212775!GO:0046822;regulation of nucleocytoplasmic transport;0.0436875423136434!GO:0006405;RNA export from nucleus;0.0442032272525127!GO:0016408;C-acyltransferase activity;0.044364921342416!GO:0016584;nucleosome positioning;0.0446590124423278!GO:0009303;rRNA transcription;0.0448286337752972!GO:0033239;negative regulation of amine metabolic process;0.0466745468331045!GO:0045763;negative regulation of amino acid metabolic process;0.0466745468331045!GO:0001933;negative regulation of protein amino acid phosphorylation;0.0466745468331045!GO:0007242;intracellular signaling cascade;0.0472453796188055!GO:0051651;maintenance of cellular localization;0.0474021907298976!GO:0004656;procollagen-proline 4-dioxygenase activity;0.0475927505483531!GO:0031545;peptidyl-proline 4-dioxygenase activity;0.0475927505483531!GO:0030149;sphingolipid catabolic process;0.048095185795112!GO:0005507;copper ion binding;0.0483388868590534!GO:0000079;regulation of cyclin-dependent protein kinase activity;0.048676980758789!GO:0006635;fatty acid beta-oxidation;0.0487471723649913 | |||
|sample_id=11366 | |sample_id=11366 | ||
|sample_note= | |sample_note= |
Revision as of 21:16, 25 June 2012
Name: | Smooth Muscle Cells - Subclavian Artery, donor2 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11990
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11990
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.229 |
10 | 10 | 0.645 |
100 | 100 | 0.973 |
101 | 101 | 0.848 |
102 | 102 | 0.955 |
103 | 103 | 0.0246 |
104 | 104 | 0.443 |
105 | 105 | 0.296 |
106 | 106 | 0.0219 |
107 | 107 | 0.0259 |
108 | 108 | 0.216 |
109 | 109 | 0.0857 |
11 | 11 | 0.0694 |
110 | 110 | 0.203 |
111 | 111 | 0.924 |
112 | 112 | 0.369 |
113 | 113 | 0.169 |
114 | 114 | 0.148 |
115 | 115 | 0.0198 |
116 | 116 | 0.0564 |
117 | 117 | 0.546 |
118 | 118 | 0.46 |
119 | 119 | 0.266 |
12 | 12 | 0.456 |
120 | 120 | 0.0446 |
121 | 121 | 0.571 |
122 | 122 | 0.217 |
123 | 123 | 0.193 |
124 | 124 | 0.752 |
125 | 125 | 0.319 |
126 | 126 | 0.623 |
127 | 127 | 0.483 |
128 | 128 | 0.0728 |
129 | 129 | 0.727 |
13 | 13 | 0.896 |
130 | 130 | 0.907 |
131 | 131 | 0.651 |
132 | 132 | 0.781 |
133 | 133 | 0.394 |
134 | 134 | 0.529 |
135 | 135 | 0.109 |
136 | 136 | 0.982 |
137 | 137 | 0.424 |
138 | 138 | 0.813 |
139 | 139 | 0.126 |
14 | 14 | 0.931 |
140 | 140 | 0.878 |
141 | 141 | 0.857 |
142 | 142 | 0.349 |
143 | 143 | 0.0341 |
144 | 144 | 0.821 |
145 | 145 | 0.122 |
146 | 146 | 0.534 |
147 | 147 | 0.0481 |
148 | 148 | 0.0278 |
149 | 149 | 0.0242 |
15 | 15 | 0.288 |
150 | 150 | 0.275 |
151 | 151 | 0.325 |
152 | 152 | 0.0332 |
153 | 153 | 0.613 |
154 | 154 | 0.916 |
155 | 155 | 0.242 |
156 | 156 | 0.739 |
157 | 157 | 0.603 |
158 | 158 | 0.033 |
159 | 159 | 0.307 |
16 | 16 | 0.046 |
160 | 160 | 0.0727 |
161 | 161 | 0.682 |
162 | 162 | 0.95 |
163 | 163 | 0.703 |
164 | 164 | 0.0792 |
165 | 165 | 0.971 |
166 | 166 | 0.386 |
167 | 167 | 0.985 |
168 | 168 | 0.542 |
169 | 169 | 0.0258 |
17 | 17 | 0.166 |
18 | 18 | 0.0764 |
19 | 19 | 0.0362 |
2 | 2 | 0.32 |
20 | 20 | 0.563 |
21 | 21 | 0.229 |
22 | 22 | 0.227 |
23 | 23 | 0.0717 |
24 | 24 | 0.699 |
25 | 25 | 0.517 |
26 | 26 | 0.189 |
27 | 27 | 0.415 |
28 | 28 | 0.258 |
29 | 29 | 0.151 |
3 | 3 | 0.247 |
30 | 30 | 0.543 |
31 | 31 | 0.455 |
32 | 32 | 4.64691e-5 |
33 | 33 | 0.827 |
34 | 34 | 0.772 |
35 | 35 | 0.324 |
36 | 36 | 0.367 |
37 | 37 | 0.0619 |
38 | 38 | 0.668 |
39 | 39 | 0.292 |
4 | 4 | 0.956 |
40 | 40 | 0.551 |
41 | 41 | 0.507 |
42 | 42 | 0.549 |
43 | 43 | 0.185 |
44 | 44 | 0.0418 |
45 | 45 | 0.552 |
46 | 46 | 0.0809 |
47 | 47 | 0.214 |
48 | 48 | 0.273 |
49 | 49 | 0.482 |
5 | 5 | 0.589 |
50 | 50 | 0.69 |
51 | 51 | 0.636 |
52 | 52 | 0.963 |
53 | 53 | 0.425 |
54 | 54 | 0.432 |
55 | 55 | 0.271 |
56 | 56 | 0.536 |
57 | 57 | 0.461 |
58 | 58 | 0.982 |
59 | 59 | 0.0256 |
6 | 6 | 0.615 |
60 | 60 | 0.306 |
61 | 61 | 0.868 |
62 | 62 | 0.505 |
63 | 63 | 0.158 |
64 | 64 | 0.44 |
65 | 65 | 0.283 |
66 | 66 | 0.789 |
67 | 67 | 0.0999 |
68 | 68 | 0.701 |
69 | 69 | 0.183 |
7 | 7 | 0.952 |
70 | 70 | 0.0567 |
71 | 71 | 0.264 |
72 | 72 | 0.923 |
73 | 73 | 0.0114 |
74 | 74 | 0.289 |
75 | 75 | 0.223 |
76 | 76 | 0.996 |
77 | 77 | 0.00402 |
78 | 78 | 0.64 |
79 | 79 | 0.00175 |
8 | 8 | 0.0517 |
80 | 80 | 0.715 |
81 | 81 | 0.267 |
82 | 82 | 0.309 |
83 | 83 | 0.298 |
84 | 84 | 0.583 |
85 | 85 | 0.0168 |
86 | 86 | 0.469 |
87 | 87 | 0.0347 |
88 | 88 | 0.0978 |
89 | 89 | 0.00488 |
9 | 9 | 0.485 |
90 | 90 | 0.593 |
91 | 91 | 0.271 |
92 | 92 | 0.0995 |
93 | 93 | 0.419 |
94 | 94 | 0.339 |
95 | 95 | 0.181 |
96 | 96 | 0.763 |
97 | 97 | 0.725 |
98 | 98 | 0.932 |
99 | 99 | 0.00966 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs11990
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000175 human smooth muscle cell of subclavian artery sample
FF:0000210 human sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000055 (non-terminally differentiated cell)
0000723 (somatic stem cell)
0000048 (multi fate stem cell)
0000548 (animal cell)
0000034 (stem cell)
0000680 (muscle precursor cell)
0002321 (embryonic cell)
0002371 (somatic cell)
0000393 (electrically responsive cell)
0000183 (contractile cell)
0000187 (muscle cell)
0000192 (smooth muscle cell)
0000211 (electrically active cell)
0000056 (myoblast)
0000255 (eukaryotic cell)
0000359 (vascular associated smooth muscle cell)
0000222 (mesodermal cell)
0002595 (smooth muscle cell of the subclavian artery)
0000355 (multi-potent skeletal muscle stem cell)
0000514 (smooth muscle myoblast)
UBERON: Anatomy
0000468 (multi-cellular organism)
0000922 (embryo)
0001134 (skeletal muscle tissue)
0001637 (artery)
0002100 (trunk)
0000483 (epithelium)
0000926 (mesoderm)
0000479 (tissue)
0000055 (vessel)
0004111 (anatomical conduit)
0000475 (organism subdivision)
0004120 (mesoderm-derived structure)
0000025 (tube)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000480 (anatomical group)
0000923 (germ layer)
0003914 (epithelial tube)
0002050 (embryonic structure)
0005423 (developing anatomical structure)
0000477 (anatomical cluster)
0000481 (multi-tissue structure)
0000467 (anatomical system)
0001062 (anatomical entity)
0000119 (cell layer)
0000490 (unilaminar epithelium)
0009569 (subdivision of trunk)
0005291 (embryonic tissue)
0003509 (arterial blood vessel)
0004573 (systemic artery)
0002036 (striated muscle tissue)
0002385 (muscle tissue)
0003834 (thoracic segment blood vessel)
0001981 (blood vessel)
0002049 (vasculature)
0000486 (multilaminar epithelium)
0007500 (epithelial tube open at both ends)
0003104 (mesenchyme)
0005256 (trunk mesenchyme)
0003513 (trunk blood vessel)
0006598 (presumptive structure)
0007798 (vascular system)
0001015 (musculature)
0002532 (epiblast (generic))
0001533 (subclavian artery)
0002329 (somite)
0002204 (musculoskeletal system)
0004535 (cardiovascular system)
0004571 (systemic arterial system)
0000383 (musculature of body)
0000915 (thoracic segment of trunk)
0004572 (arterial system)
0004537 (blood vasculature)
0003077 (paraxial mesoderm)
0004290 (dermomyotome)
0009142 (entire embryonic mesenchyme)
0003081 (lateral plate mesoderm)
0001009 (circulatory system)
0006603 (presumptive mesoderm)
0003082 (myotome)
0004872 (splanchnic layer of lateral plate mesoderm)
0006965 (vascular cord)
0003059 (presomitic mesoderm)
0007282 (presumptive segmental plate)
0009618 (trunk paraxial mesoderm)
0007285 (presumptive paraxial mesoderm)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA